Evidence map›Paper›PMID 32843537›Full record

ArticlemSystems2020

Multidimensional Proteome Profiling of Blood-Brain Barrier Perturbation by Group B

Anaamika Campeau, Robert H Mills, Marie Blanchette, Kaja Bajc, Mario Malfavon, Roeben N Munji, Liwen Deng, Bryan Hancock, Kathryn A Patras, Joshua Olson and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSystems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Anaamika CampeauDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Robert H MillsDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Marie BlanchetteDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Kaja BajcDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Mario MalfavonDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Roeben N MunjiDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Liwen DengDepartment of Immunology and Microbiology, University of Colorado, Aurora, Colorado, USA.
Bryan HancockSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.
Kathryn A PatrasDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.ORCID https://orcid.org/0000-0003-2631-8810
Joshua OlsonDivision of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.
Victor NizetSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.ORCID https://orcid.org/0000-0003-3847-0422
Richard DanemanDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Kelly DoranDepartment of Immunology and Microbiology, University of Colorado, Aurora, Colorado, USA.ORCID https://orcid.org/0000-0003-4232-6837
David J GonzalezDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA djgonzalez@ucsd.edu.ORCID https://orcid.org/0000-0003-1423-5970
University of California San Diego · USUniversity of Colorado Anschutz Medical Campus · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
Rheumatic Diseases Research Training GrantT32AR064194 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GARY S FIRESTEIN, Monica Guma · 2013 to 2026
$3.8M
Contribution of the peptidome to CA-MRSA virulenceR01AI148417 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GONZALEZ, DAVID J · 2020 to 2024
$2.0M
Regulation of blood-brain barrier formation and function by EHDsR01NS091281 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DANEMAN, RICHARD · 2015 to 2019
$1.9M
Modulation of Blood-Brain Barrier Defense and Dysfunction during Bacterial MeningitisR01NS116716 · NINDS · UNIVERSITY OF COLORADO DENVER · PI DORAN, KELLY S · 2020 to 2024
$1.9M
Blood Brain Barrier Failure in Bacterial MeningitisR56NS051247 · NINDS · UNIVERSITY OF COLORADO DENVER · PI DORAN, KELLY S · 2016 to 2018
$765k
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific EffectorProteinsR21AI149090 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GONZALEZ, DAVID J · 2020 to 2021
$433k
NIAID NIH HHS R01 AI148417NIAID NIH HHS R21 AI149090NIAMS NIH HHS T32 AR064194NIDDK NIH HHS T32 DK007202NIGMS NIH HHS T32 GM007752NINDS NIH HHS R01 NS091281NINDS NIH HHS R01 NS116716NINDS NIH HHS R56 NS051247
6 · The paper itself

Abstract

Group B

Indexed as

blood-brain barriergroup B StreptococcusmeningitismultiplexingproteomicsTMT

Identifiers

PMID32843537
PMCPMC7449606
OpenAlexW3081236114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.